Mi SciELO
Servicios personalizadosServicios Personalizados
Revista
Articulo
Inglés (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Citado por Google 
Similares en
SciELO 
Similares en Google
Compartir
Permalink
Ars Pharmaceutica (Internet)
versión On-line ISSN 2340-9894
Resumen
MONTES, Alfredo; MONTES-UCROS, Snaider y ARRIETA, Eduardo. Potential pharmacological candidates Transmembrane protease, serine 2 inhibitors 2019-ncov treatmentCandidatos potenciales farmacológicos inhibidores de proteasa transmembrana de serina 2 en el tratamiento de 2019-ncov. Ars Pharm [online]. 2020, vol.61, n.4, pp.253-257. Epub 11-Ene-2021. ISSN 2340-9894. https://dx.doi.org/10.30827/ars.v61i4.15688.
Introduction:
Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus with characteristic of infecting the respiratory tract, causing severe acute respiratory syndrome. The virus uses the ACE II receptors and the transmembrane protein TMPRSS2 initial step to enter the host cell, this contribution described different types of drug, to perform its inhibition in initial step adhesion.
Methodology:
Non-systematic review of articles with the help of preset keywords
Results:
In this review we will present drugs that inhibitors of this type of receptor therefore these drugs could be considered potential candidates to mitigate the spread of SARS-CoV-2.
Palabras clave : TMPRSS2; ACE II; COVID-19; 2019-nCoV; Coronaviridae.
